Annual Total Liabilities
$206.13 M
+$14.41 M+7.52%
31 December 2022
Summary:
Mirati Therapeutics annual total liabilities is currently $206.13 million, with the most recent change of +$14.41 million (+7.52%) on 31 December 2022. During the last 3 years, it has risen by +$14.41 million (+7.52%).MRTX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$183.24 M
-$2.85 M-1.53%
30 September 2023
Summary:
Mirati Therapeutics quarterly total liabilities is currently $183.24 million, with the most recent change of -$2.85 million (-1.53%) on 30 September 2023.MRTX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRTX Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +7.5% | -4.4% |
| 5 y5 years | +313.1% | +267.2% |
MRTX Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | at high | -19.2% |
Mirati Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $183.24 M(-1.5%) |
| June 2023 | - | $186.09 M(+8.7%) |
| Mar 2023 | - | $171.13 M(-17.0%) |
| Dec 2022 | $206.13 M(+7.5%) | $206.13 M(+18.4%) |
| Sept 2022 | - | $174.03 M(+3.7%) |
| June 2022 | - | $167.79 M(-2.5%) |
| Mar 2022 | - | $172.02 M(-10.3%) |
| Dec 2021 | $191.72 M(+66.2%) | $191.72 M(+13.2%) |
| Sept 2021 | - | $169.41 M(-25.3%) |
| June 2021 | - | $226.78 M(+86.8%) |
| Mar 2021 | - | $121.42 M(+5.3%) |
| Dec 2020 | $115.34 M(+131.1%) | $115.34 M(+67.4%) |
| Sept 2020 | - | $68.91 M(+16.9%) |
| June 2020 | - | $58.95 M(+3.0%) |
| Mar 2020 | - | $57.22 M(+14.7%) |
| Dec 2019 | $49.91 M(+85.7%) | $49.91 M(+37.8%) |
| Sept 2019 | - | $36.21 M(+25.0%) |
| June 2019 | - | $28.98 M(+12.3%) |
| Mar 2019 | - | $25.81 M(-4.0%) |
| Dec 2018 | $26.88 M(+92.6%) | $26.88 M(+18.9%) |
| Sept 2018 | - | $22.60 M(+20.0%) |
| June 2018 | - | $18.84 M(+12.8%) |
| Mar 2018 | - | $16.70 M(+19.7%) |
| Dec 2017 | $13.96 M(-7.8%) | $13.96 M(+0.4%) |
| Sept 2017 | - | $13.91 M(+15.7%) |
| June 2017 | - | $12.02 M(+3.2%) |
| Mar 2017 | - | $11.65 M(-23.0%) |
| Dec 2016 | $15.13 M(+53.8%) | $15.13 M(+10.7%) |
| Sept 2016 | - | $13.67 M(-1.0%) |
| June 2016 | - | $13.81 M(+27.3%) |
| Mar 2016 | - | $10.85 M(+10.3%) |
| Dec 2015 | $9.84 M(+81.7%) | $9.84 M(+0.2%) |
| Sept 2015 | - | $9.82 M(+37.3%) |
| June 2015 | - | $7.15 M(+39.4%) |
| Mar 2015 | - | $5.13 M(-5.3%) |
| Dec 2014 | $5.42 M | $5.42 M(-2.8%) |
| Sept 2014 | - | $5.57 M(-87.6%) |
| June 2014 | - | $44.84 M(+5.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $42.72 M(+10.5%) |
| Dec 2013 | $38.65 M(+617.8%) | $38.65 M(-7.0%) |
| Sept 2013 | - | $41.56 M(+147.3%) |
| June 2013 | - | $16.80 M(+188.0%) |
| Mar 2013 | - | $5.83 M(+8.3%) |
| Dec 2012 | $5.38 M(+43.2%) | $5.38 M(+8.1%) |
| Sept 2012 | - | $4.98 M(+44.1%) |
| June 2012 | - | $3.46 M(+23.6%) |
| Mar 2012 | - | $2.80 M(-25.6%) |
| Dec 2011 | $3.76 M(-45.1%) | $3.76 M(+4.9%) |
| Sept 2011 | - | $3.58 M(-25.8%) |
| June 2011 | - | $4.83 M(-27.0%) |
| Mar 2011 | - | $6.62 M(-3.4%) |
| Dec 2010 | $6.85 M(-24.5%) | $6.85 M(-14.3%) |
| Sept 2010 | - | $8.00 M(+4.1%) |
| June 2010 | - | $7.68 M(-0.9%) |
| Mar 2010 | - | $7.75 M(-14.5%) |
| Dec 2009 | $9.07 M(-16.3%) | $9.07 M(+10.5%) |
| Sept 2009 | - | $8.21 M(-15.2%) |
| June 2009 | - | $9.68 M(-2.2%) |
| Mar 2009 | - | $9.90 M(-8.6%) |
| Dec 2008 | $10.84 M(-61.5%) | $10.84 M(-52.5%) |
| Sept 2008 | - | $22.80 M(-15.1%) |
| June 2008 | - | $26.87 M(-1.3%) |
| Mar 2008 | - | $27.21 M(-3.4%) |
| Dec 2007 | $28.17 M(+14.7%) | $28.17 M(+5.0%) |
| Sept 2007 | - | $26.82 M(+11.0%) |
| June 2007 | - | $24.15 M(+5.0%) |
| Mar 2007 | - | $23.00 M(-6.4%) |
| Dec 2006 | $24.57 M(+311.6%) | $24.57 M(-3.2%) |
| Sept 2006 | - | $25.37 M(-2.0%) |
| June 2006 | - | $25.88 M(+2.0%) |
| Mar 2006 | - | $25.37 M(+325.1%) |
| Dec 2005 | $5.97 M(+2.7%) | $5.97 M(+8.3%) |
| Sept 2005 | - | $5.51 M(+6.9%) |
| June 2005 | - | $5.15 M(-3.9%) |
| Mar 2005 | - | $5.36 M |
| Dec 2004 | $5.81 M(-28.2%) | - |
| Dec 2003 | $8.10 M | - |
FAQ
- What is Mirati Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Mirati Therapeutics?
- What is Mirati Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Mirati Therapeutics?
What is Mirati Therapeutics annual total liabilities?
The current annual total liabilities of MRTX is $206.13 M
What is the all time high annual total liabilities for Mirati Therapeutics?
Mirati Therapeutics all-time high annual total liabilities is $206.13 M
What is Mirati Therapeutics quarterly total liabilities?
The current quarterly total liabilities of MRTX is $183.24 M
What is the all time high quarterly total liabilities for Mirati Therapeutics?
Mirati Therapeutics all-time high quarterly total liabilities is $226.78 M